Advertising

St. Louis Women Do Not Protect Themselves From Cervical Cancer

Advertisement
2009-03-26 14:21

When it comes to cervical cancer, many St. Louis women are not accessing the tools available to protect themselves from this preventable disease, according to recent survey findings released by the National Women's Health Resource Center (NWHRC), a non-profit organization dedicated to providing health education to women. The survey shows that while many St. Louis women are aware of important prevention tools like the HPV vaccine, the Pap test and the HPV test, they are missing the annual physician visits where they could receive these technologies.

In fact, although most (83 percent) think the exams are "extremely important" or "very important," nearly half (45 percent) of those surveyed had not had a gynecologic/pelvic exam in the past year.

The survey explored women's awareness of the human papillomavirus (HPV), which causes cervical cancer, and the tools to prevent the disease, including the Pap test, the HPV test and the HPV vaccine. A Pap test detects abnormal cells caused by HPV that can lead to cervical cancer, while the HPV test checks for high-risk strains of the virus itself—identifying women most at risk for developing cervical cancer. The HPV vaccine protects against the two 'high-risk' types of HPV that cause 70 percent of cervical cancers. Key findings include:

* Seventy-seven percent of St. Louis women surveyed have seen or read about HPV and most (73 percent) recognized that cervical cancer is caused by the human papillomavirus (HPV). Three quarters (75 percent) of St. Louis women surveyed were aware of the HPV vaccine.

* While half (50 percent) of women surveyed have seen or read about the HPV test, only 9 percent of women reported getting the HPV test. The HPV test is recommended along with a Pap test for women 30 and older, because HPV infections are more likely to be persistent at this age, and therefore more likely to increase a woman's risk for cervical cancer. The test may also be used in women under 30 as a follow-up to an inconclusive Pap test.

Pages

Advertisement
Subscribe to EmaxHealth on YouTube